Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.42 |
| ▸ | NAMPT | P43490 | 5/20 | 0.42 |
| ▸ | IDE | P14735 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.40 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31558522 | 0.84 | MTNR1B (0.45) | ALDH1A1LMNAMAPTNTRK1PPARG | |
| SCHEMBL31750757 | 0.80 | PPARG (0.42) | ALDH1A1LMNAMAPTNTRK1PPARG | |
| SCHEMBL30765549 | 0.76 | PPARG (0.44) | ALDH1A1LMNAMAPTKMT2APPARG | |
| SCHEMBL10552139 | 0.76 | PIK3C3 (0.48) | ALDH1A1LMNAMAPTPPARGPPARD | |
| SCHEMBL27113334 | 0.76 | PPARG (0.44) | ALDH1A1LMNAMAPTKMT2APPARG | |
| SCHEMBL27152696 | 0.76 | HTR2C (0.41) | ALDH1A1KMT2AIDE | |
| SCHEMBL27144119 | 0.75 | GAA (0.45) | ALDH1A1LMNATSHR | |
| Hydrochloric Acid SCHEMBL31558473 | 0.75 | PPARG (0.43) | ALDH1A1LMNAMAPTKMT2APPARG | |
| Hydrochloric Acid SCHEMBL27153852 | 0.75 | PPARG (0.43) | ALDH1A1LMNAMAPTKMT2APPARG | |
| SCHEMBL30765718 | 0.74 | NTRK1 (0.45) | KMT2ANTRK1PPARGPPARAIDE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062443-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMA INC (US) | 2026-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062443-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | C9, SSB, C1S | ALDH1A1 3835/4885LMNA 345/4885MAPT 1355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.